#Patient Identifier	Subtype	TCGA PanCanAtlas Cancer Type Acronym	Other Patient ID	Diagnosis Age	Sex	Neoplasm Disease Stage American Joint Committee on Cancer Code	American Joint Committee on Cancer Publication Version Type	Last Communication Contact from Initial Pathologic Diagnosis Date	Birth from Initial Pathologic Diagnosis Date	Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value	Ethnicity Category	Form completion date	Neoadjuvant Therapy Type Administered Prior To Resection Text	ICD-10 Classification	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code	Informed consent verified	New Neoplasm Event Post Initial Therapy Indicator	American Joint Committee on Cancer Metastasis Stage Code	Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code	American Joint Committee on Cancer Tumor Stage Code	Person Neoplasm Cancer Status	Primary Lymph Node Presentation Assessment	Prior Diagnosis	Race Category	Radiation Therapy	Patient Weight	In PanCan Pathway Analysis	Overall Survival Status	Overall Survival (Months)	Disease-specific Survival status	Months of disease-specific survival	Disease Free Status	Disease Free (Months)	Progression Free Status	Progress Free Survival (Months)	Genetic Ancestry Label#Identifier to uniquely specify a patient.	Subtype	Text field to hold cancer type acronym used by TCGA PanCanAtlas.	Legacy DMP patient identifier (DMPnnnn)	Age at which a condition or disease was first diagnosed.	Sex	The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria.	The version or edition of the American Joint Committee on Cancer Cancer Staging Handbooks, a publication by the group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.	Time interval from the date of last followup to the date of initial pathologic diagnosis, represented as a calculated number of days..	Time interval from a person's date of birth to the date of initial pathologic diagnosis, represented as a calculated number of days.	Time interval from the last day on which a person is known to be alive to the date of initial pathologic diagnosis, represented as a calculated number of days.	The text for reporting information about ethnicity.	Form completion date	Text term to describe the patient's history of neoadjuvant treatment and the kind of treatment given prior to resection of the tumor.	10th revision of the International Statistical Classification of Diseases and Related Health Problems.	The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains._A system of numbered categories for representation of data.	The third edition of the International Classification of Diseases for Oncology, published in 2000, used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms._The description of an anatomical region or of a body part._Named locations of, or within, the body._A system of numbered categories for representation of data.	Informed consent verified	Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.	Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC).	The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual.	Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC).	Person neoplasm cancer status.	Primary lymph node presentation assessment.	Prior diagnosis.	The text for reporting information about race.	Radiation Therapy.	Weight measured in kilograms.	Patient Part of PanCan Pathway Analysis	Overall patient survival status.	Overall survival in months since initial diagonosis.	The time period usually begins at the time of diagnosis or at the start of treatment and ends at the time of death.	The time period (months) usually begins at the time of diagnosis or at the start of treatment and ends at the time of death.	Disease free status since initial treatment.	Disease free (months) since initial treatment.	Progression Free Status	Progress Free Survival (Months)	Genetic ancestries were determined using five different methods as described in Carrot-Zhang et al (2020). These consensus calls were created based on the ancestral population that received the majority of assignments for each patient.#STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	STRING	NUMBER	NUMBER	NUMBER	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	STRING	NUMBER	STRING	NUMBER	STRING	NUMBER	STRING	NUMBER	STRING#1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	9	1	1	1	1	1	1	1	1PATIENT_ID	SUBTYPE	CANCER_TYPE_ACRONYM	OTHER_PATIENT_ID	AGE	SEX	AJCC_PATHOLOGIC_TUMOR_STAGE	AJCC_STAGING_EDITION	DAYS_LAST_FOLLOWUP	DAYS_TO_BIRTH	DAYS_TO_INITIAL_PATHOLOGIC_DIAGNOSIS	ETHNICITY	FORM_COMPLETION_DATE	HISTORY_NEOADJUVANT_TRTYN	ICD_10	ICD_O_3_HISTOLOGY	ICD_O_3_SITE	INFORMED_CONSENT_VERIFIED	NEW_TUMOR_EVENT_AFTER_INITIAL_TREATMENT	PATH_M_STAGE	PATH_N_STAGE	PATH_T_STAGE	PERSON_NEOPLASM_CANCER_STATUS	PRIMARY_LYMPH_NODE_PRESENTATION_ASSESSMENT	PRIOR_DX	RACE	RADIATION_THERAPY	WEIGHT	IN_PANCANPATHWAYS_FREEZE	OS_STATUS	OS_MONTHS	DSS_STATUS	DSS_MONTHS	DFS_STATUS	DFS_MONTHS	PFS_STATUS	PFS_MONTHS	GENETIC_ANCESTRY_LABELTCGA-3X-AAV9	CHOL	CHOL	41B97B11-ACAA-4FBC-B3B0-0ABC1BCAC13B	72	Male	STAGE I	7TH		-26349	0	Not Hispanic Or Latino	7/9/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	N0	T1	With Tumor		Yes	Asian	No	52	Yes	1:DECEASED	11.14508334	1:DEAD WITH TUMOR	11.14508334	1:Recurred/Progressed	7.101292041	1:PROGRESSION	7.101292041	EUR_ADMIXTCGA-3X-AAVA	CHOL	CHOL	FE57B639-DB7A-460F-ADFE-552F1E034E46	50	Female	STAGE II	7TH		-18303	0	Not Hispanic Or Latino	9/2/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	NX	T2B	With Tumor		No	White	No	92	Yes	1:DECEASED	14.62997666	1:DEAD WITH TUMOR	14.62997666	1:Recurred/Progressed	8.679356939	1:PROGRESSION	8.679356939	EURTCGA-3X-AAVB	CHOL	CHOL	3824CD6D-C85C-4B21-819A-932D1AFEF976	70	Female	STAGE IVB	7TH	402	-25819	0	Not Hispanic Or Latino	7/9/14	No	C24.0	8160/3	C24.0	Yes		M1	N1	T3			No	White		76	Yes	0:LIVING	13.21629352	0:ALIVE OR DEAD TUMOR FREE	13.21629352			0:CENSORED	13.21629352	EURTCGA-3X-AAVC	CHOL	CHOL	FF4131C9-537C-46CC-B495-9AF60D431F5E	72	Female	STAGE I	7TH	709	-26493	0	Not Hispanic Or Latino	7/11/14	No	C24.0	8160/3	C24.0	Yes	No	M0	N0	T1	Tumor Free		No	White	No	104	Yes	0:LIVING	23.3093336	0:ALIVE OR DEAD TUMOR FREE	23.3093336	0:DiseaseFree	23.3093336	0:CENSORED	23.3093336	EURTCGA-3X-AAVE	CHOL	CHOL	DCC87C59-FD8C-4511-9983-96D5B9784CB0	60	Male	STAGE II	7TH	309	-21943	0	Not Hispanic Or Latino	7/14/14	No	C22.1	8160/3	C22.1	Yes	No	M0	N0	T2	Tumor Free		No	Asian	No	59	Yes	0:LIVING	21.36962883	0:ALIVE OR DEAD TUMOR FREE	21.36962883	0:DiseaseFree	21.36962883	0:CENSORED	21.36962883	EASTCGA-4G-AAZO	CHOL	CHOL	0775583E-C0A0-4F18-9CA2-8F89CEDCE3D6	71	Female	STAGE II	7TH	609	-25989	0	Not Hispanic Or Latino	7/26/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	N0	T2A	With Tumor		No	White	No	67	Yes	0:LIVING	38.69546635	0:ALIVE OR DEAD TUMOR FREE	38.69546635			1:PROGRESSION	13.93957327	EURTCGA-4G-AAZT	CHOL	CHOL	B10C64C2-7FD2-4210-B975-034AFFB14B57	62	Male	STAGE I	7TH	206	-22777	0	Not Hispanic Or Latino	7/28/14	No	C22.1	8160/3	C22.1	Yes	No	M0	N0	T1	Tumor Free		No	White	No	65	Yes	0:LIVING	13.80806786	0:ALIVE OR DEAD TUMOR FREE	13.80806786	0:DiseaseFree	13.80806786	0:CENSORED	13.80806786	EURTCGA-W5-AA2G	CHOL	CHOL	22BF93B3-C8DC-4669-862F-3E4AE478849B	62	Female	STAGE I	7TH	1976	-22933	0	Not Hispanic Or Latino	5/22/14	No	C22.1	8160/3	C22.1	Yes	No	M0	N0	T1	Tumor Free		No	White	No	52	Yes	0:LIVING	64.96367163	0:ALIVE OR DEAD TUMOR FREE	64.96367163	0:DiseaseFree	64.96367163	0:CENSORED	64.96367163	EURTCGA-W5-AA2H	CHOL	CHOL	BC15CEC4-1F82-47FE-AE69-3853194FAB7E	70	Female	STAGE III	7TH	635	-25775	0	Not Hispanic Or Latino	5/22/14	No	C22.1	8160/3	C22.1	Yes	No	M0	N0	T3	Tumor Free		No	White	No	71	Yes	0:LIVING	35.40783115	0:ALIVE OR DEAD TUMOR FREE	35.40783115	0:DiseaseFree	35.40783115	0:CENSORED	35.40783115	EURTCGA-W5-AA2I	CHOL	CHOL	3C8CA064-A4A7-416F-A069-4324D4A72038	66	Male	STAGE I	6TH		-24388	0	Not Hispanic Or Latino	5/22/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	N0	T1	With Tumor		No	White	No	125	Yes	1:DECEASED	63.74724661	1:DEAD WITH TUMOR	63.74724661	0:DiseaseFree	63.74724661	1:PROGRESSION	7.134168393	EURTCGA-W5-AA2O	CHOL	CHOL	180A2B9C-9CAC-4D96-86E8-CD6B3B9386B5	57	Male	STAGE I	6TH		-21118	0	Not Hispanic Or Latino	5/23/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	N0	T1	With Tumor		No	White	No	73	Yes	1:DECEASED	21.04086531	1:DEAD WITH TUMOR	21.04086531	1:Recurred/Progressed	7.068415689	1:PROGRESSION	7.068415689	EURTCGA-W5-AA2Q	CHOL	CHOL	F47DBD99-920B-4B39-A1B0-6C152AD24884	68	Male	STAGE II	6TH	50	-25069	0	Not Hispanic Or Latino	5/23/14	No	C22.1	8160/3	C22.1	Yes	No	M0	N0	T2B	Tumor Free		No	White	No	67	Yes	0:LIVING	1.643817602	0:ALIVE OR DEAD TUMOR FREE	1.643817602	0:DiseaseFree	1.643817602	0:CENSORED	1.643817602	EURTCGA-W5-AA2R	CHOL	CHOL	20BF79AF-3B0F-477D-B619-5597D42F5D5E	77	Female	STAGE I	6TH	1485	-28367	0	Not Hispanic Or Latino	5/23/14	No	C22.1	8160/3	C22.1	Yes	No	M0	N0	T1	Tumor Free		No	White	No	72	Yes	0:LIVING	50.69533485	0:ALIVE OR DEAD TUMOR FREE	50.69533485	0:DiseaseFree	50.69533485	0:CENSORED	50.69533485	EURTCGA-W5-AA2T	CHOL	CHOL	8944FE2A-E32F-4898-A2C5-FB6751F602A4	64	Female	STAGE II	6TH		-23560	0	Not Hispanic Or Latino	5/24/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	N0	T2	With Tumor		Yes	White	No	62	Yes	1:DECEASED	40.10914949	1:DEAD WITH TUMOR	40.10914949	1:Recurred/Progressed	9.698523852	1:PROGRESSION	9.698523852	EURTCGA-W5-AA2U	CHOL	CHOL	AAACF22C-2362-4613-B024-88FB7DD1CCA1	78	Female	STAGE I	7TH		-28552	0	Not Hispanic Or Latino	5/24/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	N0	T1	With Tumor		No	White	No	60	Yes	1:DECEASED	20.61347273	1:DEAD WITH TUMOR	20.61347273	0:DiseaseFree	20.61347273	1:PROGRESSION	3.123253444	EURTCGA-W5-AA2W	CHOL	CHOL	1D136284-BDF5-498E-9506-4893801A337C	31	Female	STAGE IVA	7TH		-11438	0	Not Hispanic Or Latino	5/24/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	N1	T2A	With Tumor		No	White	No	91	Yes	1:DECEASED	30.37774929	1:DEAD WITH TUMOR	30.37774929			1:PROGRESSION	7.791695434	EURTCGA-W5-AA2X	CHOL	CHOL	6E534DD3-81AC-4575-AB1E-02C21E10916D	67	Male	STAGE IVB	7TH		-24797	0	Not Hispanic Or Latino	5/24/14	No	C24.0	8160/3	C24.0	Yes		M1	N1	T2B			No	White	No	88	Yes	1:DECEASED	8.909491403		8.909491403			0:CENSORED	8.909491403	EURTCGA-W5-AA2Z	CHOL	CHOL	20EC1CD9-7BDB-4EB9-9D20-65795580F1F5	29	Female	STAGE II	7TH	155	-10659	0	Not Hispanic Or Latino	5/24/14	No	C22.1	8160/3	C22.1	Yes	No	M0	N0	T2	With Tumor		No	White	No	82	Yes	0:LIVING	53.06243219	0:ALIVE OR DEAD TUMOR FREE	53.06243219			0:CENSORED	53.06243219	EURTCGA-W5-AA30	CHOL	CHOL	B4F7F9E4-5FC5-4461-8E0B-0B6C384863C6	82	Male	STAGE I	7TH	1079	-30039	0	Not Hispanic Or Latino	5/24/14	No	C22.1	8160/3	C22.1	Yes	No	M0	N0	T1	Tumor Free		No	White	No	102	Yes	0:LIVING	37.9064339	0:ALIVE OR DEAD TUMOR FREE	37.9064339	0:DiseaseFree	37.9064339	0:CENSORED	37.9064339	EURTCGA-W5-AA31	CHOL	CHOL	2D6E20B2-82C7-4C12-92D0-93282B0A9031	71	Male	STAGE I	7TH	10	-26139	0	Not Hispanic Or Latino	5/27/14	No	C22.1	8160/3	C22.1	Yes	No	M0	N0	T1	Tumor Free		Yes	White	No	105	Yes	0:LIVING	0.32876352	0:ALIVE OR DEAD TUMOR FREE	0.32876352	0:DiseaseFree	0.32876352	0:CENSORED	0.32876352	EURTCGA-W5-AA33	CHOL	CHOL	5FB3AFFA-3661-48E8-A1CC-B533C862E8C5	60	Male	STAGE I	7TH	1070	-22090	0	Not Hispanic Or Latino	5/27/14	No	C22.1	8160/3	C22.1	Yes	No	M0	N0	T1	Tumor Free		No	White	No	128	Yes	0:LIVING	47.63783411	0:ALIVE OR DEAD TUMOR FREE	47.63783411	0:DiseaseFree	47.63783411	0:CENSORED	47.63783411	EURTCGA-W5-AA34	CHOL	CHOL	ADC9A685-5B4A-4C29-881A-DA1895C47520	75	Female	STAGE I	7TH	168	-27535	0	Not Hispanic Or Latino	5/27/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	N0	T1	With Tumor		No	White	No	71	Yes	1:DECEASED	18.24637538	1:DEAD WITH TUMOR	18.24637538	1:Recurred/Progressed	1.315054082	1:PROGRESSION	1.315054082	EURTCGA-W5-AA36	CHOL	CHOL	F2D42E03-CA8D-4B57-AE39-0CC8F37B1B67	51	Female	STAGE IV	6TH		-18882	0	Not Hispanic Or Latino	5/27/14	Yes	C22.1	8160/3	C22.1	Yes	Yes	M1	N0	T3	With Tumor		No	White	No	68	Yes	1:DECEASED	46.09264556	1:DEAD WITH TUMOR	46.09264556			1:PROGRESSION	11.90123944	EURTCGA-W5-AA38	CHOL	CHOL	48D17B17-348C-405A-AE92-F190372A3AAC	55	Female	STAGE I	7TH	964	-20285	0	Not Hispanic Or Latino	5/27/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	N0	T1	Tumor Free		No	White	No	73	Yes	0:LIVING	48.36111385	0:ALIVE OR DEAD TUMOR FREE	48.36111385	1:Recurred/Progressed	12.39438472	1:PROGRESSION	12.39438472	EURTCGA-W5-AA39	CHOL	CHOL	32E9558C-946B-4288-91E1-504E47C308AC	81	Male	STAGE II	7TH		-29594	0	Not Hispanic Or Latino	5/27/14	No	C22.1	8160/3	C22.1	Yes		M0	N0	T2	With Tumor		No	White	No	80	Yes	1:DECEASED	5.588979847	1:DEAD WITH TUMOR	5.588979847			1:PROGRESSION	5.588979847	EURTCGA-W6-AA0S	CHOL	CHOL	7047DC12-E2ED-40B7-86FD-C5C53A2766FD	46	Female	STAGE I	7TH	549	-16951	0	Hispanic Or Latino	8/16/14	No	C22.1	8160/3	C22.1	Yes	Yes	MX	N0	T1	Tumor Free		No	White	No	61	Yes	0:LIVING	26.56409245	0:ALIVE OR DEAD TUMOR FREE	26.56409245	1:Recurred/Progressed	18.04911727	1:PROGRESSION	18.04911727	 TCGA-WD-A7RX	CHOL	CHOL	4290B3B3-94F6-43E4-8309-430DD973AE2D	71	Female	STAGE II	7TH		-26006	0	Hispanic Or Latino	12/23/13	No	C22.0	8160/3	C22.0	Yes	No	MX	NX	T2B	Tumor Free		No	White	No	51	Yes	1:DECEASED	0.690403393	0:ALIVE OR DEAD TUMOR FREE	0.690403393			0:CENSORED	0.690403393	 TCGA-YR-A95A	CHOL	CHOL	779CE92D-1ABD-44FC-9021-EDA4D7F08FFF	52	Male	STAGE IV	6TH		-19292	0		10/23/14	No	C24.0	8160/3	C24.0	Yes	Yes	M1	NX	T2	With Tumor		No	White	No	77	Yes	1:DECEASED	0.854785153	1:DEAD WITH TUMOR	0.854785153			1:PROGRESSION	0.558897985	EURTCGA-ZD-A8I3	CHOL	CHOL	CCB028AE-777C-4AF6-B92E-40848F1CF774	73	Female	STAGE II	7TH	0	-26754	0	Not Hispanic Or Latino	12/29/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	N0	T2	Tumor Free		No	Asian	No	49	Yes	1:DECEASED	5.556103495	1:DEAD WITH TUMOR	5.556103495	1:Recurred/Progressed	1.93970477	1:PROGRESSION	1.93970477	EASTCGA-ZH-A8Y1	CHOL	CHOL	B16E9C3F-C7DF-46C2-BEE3-ECAEBBAB025F	74	Female	STAGE IVA	7TH		-27279	0	Not Hispanic Or Latino	3/11/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	N1	T3	With Tumor		Yes	White	No	78	Yes	1:DECEASED	12.65739554	1:DEAD WITH TUMOR	12.65739554			1:PROGRESSION	1.61094125	EURTCGA-ZH-A8Y2	CHOL	CHOL	47A9EF9B-04F0-4E8D-BFDB-0846BA30D08B	59	Female	STAGE I	7TH		-21743	0	Not Hispanic Or Latino	3/11/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	NX	T1	With Tumor		No	Black or African American	No	80	Yes	1:DECEASED	23.04632278	1:DEAD WITH TUMOR	23.04632278	1:Recurred/Progressed	6.509517704	1:PROGRESSION	6.509517704	AFRTCGA-ZH-A8Y4	CHOL	CHOL	95B69517-4971-450E-9ED0-43BC8B2C0534	58	Male	STAGE I	7TH		-21503	0	Not Hispanic Or Latino	3/11/14	No	C22.1	8160/3	C22.1	Yes	Yes	M0	N0	T1	With Tumor		Yes	White	No	88	Yes	1:DECEASED	24.36137686	1:DEAD WITH TUMOR	24.36137686			1:PROGRESSION	9.238254923	EURTCGA-ZH-A8Y5	CHOL	CHOL	9D9109F5-5917-4126-8E34-8A7E4632E913	69	Male	STAGE IVB	7TH	1015	-25268	0	Not Hispanic Or Latino	3/11/14	No	C22.1	8160/3	C22.1	Yes	Yes	M1	N1	T3	With Tumor		No	White	No	85	Yes	0:LIVING	40.40503666	0:ALIVE OR DEAD TUMOR FREE	40.40503666			1:PROGRESSION	7.956077194	EURTCGA-ZH-A8Y6	CHOL	CHOL	5166D82F-7B22-4101-BEA9-6056E5A74C48	41	Female	STAGE I	7TH	519	-14976	0	Not Hispanic Or Latino	3/11/14	No	C22.1	8160/3	C22.1	Yes	No	M0	N0	T1	With Tumor		No	Black or African American	No	89	Yes	0:LIVING	17.06282671	0:ALIVE OR DEAD TUMOR FREE	17.06282671	0:DiseaseFree	17.06282671	0:CENSORED	17.06282671	AFRTCGA-ZH-A8Y8	CHOL	CHOL	5CF3911A-F3EA-4C0E-851D-5BB57CA7190F	73	Male	STAGE I	7TH	409	-26744	0	Not Hispanic Or Latino	3/11/14	No	C22.1	8160/3	C22.1	Yes	No	M0	N0	T1	Tumor Free		Yes	White	No	98	Yes	0:LIVING	19.79156393	0:ALIVE OR DEAD TUMOR FREE	19.79156393	0:DiseaseFree	19.79156393	0:CENSORED	19.79156393	EURTCGA-ZU-A8S4	CHOL	CHOL	E76CF9A0-061E-4A7D-BA28-5A40B8DA54B8	52	Male	STAGE I	7TH		-19264	0	Not Hispanic Or Latino	4/8/14	No	C22.1	8160/3	C22.1	Yes	Yes	MX	NX	T1	With Tumor		No	White	No	122	Yes	1:DECEASED	3.2218825	1:DEAD WITH TUMOR	3.2218825	1:Recurred/Progressed	2.367097347	1:PROGRESSION	2.367097347	EUR